Stargardt disease , także: Stargardt's disease , STGD (skrót)
fundus flavimaculatus latin
juvenile macular degeneration

At 19 he began losing his vision due to Stargardt's disease.

At 9, doctors found she had Stargardt's disease, a degenerative eye condition.

Stargardt's disease has left her with such limited sight that she is legally blind.

She was found to have Stargardt's disease, a genetically caused degenerative eye disorder.

No treatments are available for Stargardt's disease.

He competes in the T13 classification; his central vision is affected by Stargardt's disease.

Stargardt's disease, the ailment that has left Runyan with minimal vision, created the possibility of problems in a marathon.

Stargardt's disease, also called juvenile macular degeneration, is a similar illness that typically begins in late childhood.

Runyan, 34, has a hereditary condition called Stargardt's disease, which caused her retinas to begin deteriorating at age 9.

It was unreal because Runyan has Stargardt's disease, which has left her legally blind.

Goodpaster has Stargardt's disease, which is a macular degeneration of the cones in the middle of his eye.

Smyth had perfect vision up until the age of nine before the hereditary condition Stargardt's Disease began to cause his sight to deteriorate.

She has established herself among the world's elite athletes in distance running even though, because of Stargardt's disease, a degenerative eye condition, she is legally blind.

Runyan suffers from a degenerative condition of the retina called Stargardt's disease, which has left her with a hole in the center of her vision.

Also, the ABCA4 maps to a region of chromosome 1p21 that contains the gene for Stargardt's disease.

Mr. Wallsten has Stargardt's disease, a degenerative condition that causes blindness and can be painfully exacerbated by sunlight.

Because of Stargardt's disease, the childhood illness that left Runyan with little straight-ahead vision, she made special preparations for the New York City Marathon last year.

Juvenile macular degeneration is the term for several inherited eye diseases that affect children and young adults, including Stargardt's disease, Best disease, and juvenile retinoschisis.

Researchers at Moorfields Eye Hospital had already been using human embryonic stem cells to replace the pigmented lining of the retina in patients with Stargardt's disease.

This gene is found to be highly expressed in rod photoreceptors and is mutated in Stargardt's disease, recessive retinitis pigmentism, and the majority of recessive cone-rod dystrophy.

Given approved phase I/II clinical trial clearance, ACT will also use the hESC-derived RPE cells in a trial for Stargardt's Disease simultaneously.

Stargardt's disease (juvenile macular degeneration, STGD) is an autosomal recessive retinal disorder characterized by a juvenile-onset macular dystrophy, alterations of the peripheral retina, and subretinal deposition of lipofuscin-like material.

The hereditary condition, called Stargardt's disease, began causing a deterioration of the retina in Runyan's eyes at age 9, left her with 20-300 vision by age 14 and forced her to quit playing soccer because she could no longer follow the ball.

The form of Stargardt's disease that involves a butterfly pattern of dystrophy is caused by a mutation in a gene that codes a membrane bound protein that is involved in the elongation of very long chain fatty acids (ELOVL4).

Lentiviral vectors, unlike rAAV vectors, are capable of efficiently incorporating and allowing expression of transgene fragments as large as 10 kb, and previous work suggests the lentiviral vector is a possible therapeutic option for patients suffering from Stargardt's disease (see below).

Stargardt disease, or fundus flavimaculatus, is an inherited form of juvenile macular degeneration that causes progressive vision loss usually to the point of legal blindness.